Strictly regulating an industry with high demand, like healthcare or vaping, often backfires. Instead of eliminating risk, it pushes consumers and providers into a "parallel" gray market that is less regulated, less coordinated, and ultimately more harmful. The intended consumer protection fails because the regulated system becomes too difficult to operate within, forcing activity outside the "kingdom walls."

During the pandemic, Germany approved 85 vendors for COVID tests, resulting in a $1 price point. The US FDA, by contrast, approved only two, leading to $12 tests. This serves as a stark example of how regulatory bottlenecks and potential capture can inflate consumer prices and stifle market competition.

The Trump administration's strategy for lowering drug prices involves creating credible threats to bring companies to the negotiating table. This forces concessions and removes excess profit without crippling the industry's vital R&D capabilities.

While patents are important, a pharmaceutical giant's most durable competitive advantage is its ability to navigate complex global regulatory systems. This 'regulatory know-how' is a massive barrier to entry that startups cannot easily replicate, forcing them into acquisition by incumbents.

High healthcare costs are not an inherent failure of capitalism but a result of regulatory capture. Established companies influence legislation to create immense barriers to entry, stifling innovation from new competitors, which leads to ballooning administrative costs instead of more physicians and better care.

By forcing disclosure of the lowest net price, MFN could dismantle the system of confidential rebates. This is a problem for payers (health plans, PBMs) who use their ability to negotiate superior, secret rebates as a key competitive advantage. A transparent system creates a level playing field, eroding this value proposition.

Venture capitalist Bill Gurley explains "regulatory capture" as a phenomenon where established companies influence regulations to their own benefit. This tactic is used not for public good, but to block new competitors, raise prices, and solidify market dominance, particularly in industries like healthcare and finance.

By aggregating millions of users, ZocDoc acts as a collective bargaining unit for patients. It uses its marketplace power to reward providers for patient-friendly behavior (e.g., price transparency, better hours) with better visibility, proving more effective at driving change than punitive government regulations.

Regulatory capture is not an abstract problem. It has tangible negative consequences for everyday consumers, such as the elimination of free checking accounts after the Dodd-Frank Act was passed, or rules preventing physicians from opening new hospitals, which stifles competition and drives up costs.